Patent details

Basic Information

Publication number:

EP2172205

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP101512705

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Pharmaceutical formulation comprising lanthanum compounds

French Title of Invention:

Préparation pharmaceutique contenant des composés de lanthane

German Title of Invention:

Pharmazeutische Formulierung mit Lanthanum-Verbindungen

SPC Number:

Dates

Filing date:

26/08/2004

Grant date:

18/06/2014

EP Publication Date:

18/06/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/04/2010

EP B1 Publication Date:

18/06/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

26/08/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/11/2020

 

 

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, Japan (JP)

History of Owners

From:

26/08/2004

To:

03/11/2020

Name:

Shire Biopharmaceuticals Holdings Ireland Limited

Address:

22 Grenville Street, St Helier JE4 8PX, Jersey, United Kingdom (GB)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

24/06/2014

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Haslam Robert Paul

Address:

United Kingdom (GB)

2

Name:

Ferdinando Josephine Christine

Address:

United Kingdom (GB)

3

Name:

Trespidi Laura Anna

Address:

Italy (IT)

Priority

1

Priority Number:

497560 P

Priority Date:

26/08/2003

Priority Country:

United States (US)

2

Priority Number:

517078 P

Priority Date:

05/11/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/00;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2020/13

Publication date:

07/12/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20200000350A

Date Registered:

03/11/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Baker & McKenzie

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, Japan (JP)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

20/07/2023

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
03/11/2020	Request For Change	21
05/11/2020	Outgoing Correspondence	1